Cargando…
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
OBJECTIVE: Diabetic nephropathy (DN) is characterized by glomerular and tubulointerstitial injury, proteinuria and remodeling. Here we examined whether the combination of an inhibitor of neprilysin (sacubitril), a natriuretic peptide-degrading enzyme, and an angiotensin II type 1 receptor blocker (v...
Autores principales: | Habibi, Javad, Aroor, Annayya R., Das, Nitin A., Manrique-Acevedo, Camila M., Johnson, Megan S., Hayden, Melvin R., Nistala, Ravi, Wiedmeyer, Charles, Chandrasekar, Bysani, DeMarco, Vincent G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432760/ https://www.ncbi.nlm.nih.gov/pubmed/30909895 http://dx.doi.org/10.1186/s12933-019-0847-8 |
Ejemplares similares
-
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
por: Aroor, Annayya R., et al.
Publicado: (2021) -
Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
por: Dargad, Ramesh R., et al.
Publicado: (2018) -
DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the Zucker obese rat
por: Nistala, Ravi, et al.
Publicado: (2014) -
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
por: Jhund, Pardeep S, et al.
Publicado: (2016) -
In silico study of inhibitory capacity of sacubitril/valsartan toward neprilysin and angiotensin receptor
por: Jovanović, Jelena Đorović, et al.
Publicado: (2022)